Article Type
Changed
Tue, 05/21/2019 - 12:13
Display Headline
Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome

The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today. 

Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome is the fourth eNewsletter in this series.

Click here to read the supplement. 

Sponsor
Funding for this newsletter series was provided by AstraZeneca.
Issue
The Journal of Family Practice - 66(12)
Publications
Sections
Sponsor
Funding for this newsletter series was provided by AstraZeneca.
Sponsor
Funding for this newsletter series was provided by AstraZeneca.

The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today. 

Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome is the fourth eNewsletter in this series.

Click here to read the supplement. 

The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today. 

Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome is the fourth eNewsletter in this series.

Click here to read the supplement. 

Issue
The Journal of Family Practice - 66(12)
Issue
The Journal of Family Practice - 66(12)
Publications
Publications
Article Type
Display Headline
Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome
Display Headline
Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica